AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) dropped 6.8% during mid-day trading on Friday after Canaccord Genuity Group lowered their price target on the stock from $66.00 to $52.00.

AtriCure (NASDAQ:ATRC – Free Report) had its target price decreased by JPMorgan Chase & Co. from $51.00 to $46.00 in a ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC – Research Report) and Journey ...

Shaping Responsible Governance of AI and Emerging Technologies in a Future Digital Economy The Advanced Technology Research ...

Canaccord lowered the firm’s price target on AtriCure (ATRC) to $52 from $66 and keeps a Buy rating on the shares. The firm updated its model ...

Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the Barron’s newsroom and are our best ideas based on original ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...